Literature DB >> 3997647

Borreliosis in dogs from southern Connecticut.

L A Magnarelli, J F Anderson, A F Kaufmann, L L Lieberman, G D Whitney.   

Abstract

Blood samples were obtained from dogs in tick-infested regions of southern Connecticut to assess canine exposure to Borrelia burgdorferi, the etiologic agent of Lyme disease in human beings. An indirect fluorescent antibody test detected immunoglobulin (Ig)M antibodies at titers of 1:64 to 1:512 in 22 of 84 serum samples previously shown to be positive with a polyvalent rabbit anti-dog total Ig conjugate. Analyses of paired serum samples from 20 seropositive dogs revealed temporal differences in titers; changes occurred during brief (1 month) or extended (greater than 4 years) sampling periods. Clinical records for 52 seropositive dogs indicated a history of intermittent lameness in 19 of these. Limb/joint disorders typically developed in dogs without IgM antibodies, suggesting manifestation during later phases of illness. A microscopic-agglutination test was used to assess cross reactivity between B burgdorferi and 20 serovars of Leptospira interrogans and biflexa. Analyses of 63 dog serum specimens with antibodies to B burgdorferi and a series of reference rabbit sera revealed minor antigenic relatedness. There was geographic clustering of dogs with antibodies to B burgdorferi in areas of south-central and southeastern Connecticut, where human Lyme disease also occurs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997647

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  22 in total

1.  Immunoblot analysis of immunoglobulin G response to the Lyme disease agent (Borrelia burgdorferi) in experimentally and naturally exposed dogs.

Authors:  R T Greene; R L Walker; W L Nicholson; H W Heidner; J F Levine; E C Burgess; M Wyand; E B Breitschwerdt; H A Berkhoff
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

2.  Interlaboratory comparison of titers of antibody to Borrelia burgdorferi and evaluation of a commercial assay using canine sera.

Authors:  R T Greene; D A Hirsch; P L Rottman; T M Gerig
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

3.  Dogs as sentinels for human Lyme borreliosis in The Netherlands.

Authors:  H A Goossens; A E van den Bogaard; M K Nohlmans
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Quantitative approach for the serodiagnosis of canine Lyme disease by the immunoblot procedure.

Authors:  M A Guerra; E D Walker; U Kitron
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi.

Authors:  D A Jobe; S M Callister; L C Lim; S D Lovrich; R F Schell
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Active immunization of hamsters against experimental infection with Borrelia burgdorferi.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Canine seroprevalence and the distribution of Ixodes dammini in an area of emerging Lyme disease.

Authors:  P W Rand; R P Smith; E H Lacombe
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

8.  Serologic analysis of dogs, horses, and cottontail rabbits for antibodies to an antigenic flagellar epitope of Borrelia burgdorferi.

Authors:  E Fikrig; L A Magnarelli; M Chen; J F Anderson; R A Flavell
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  The distribution of canine exposure to Borrelia burgdorferi in a Lyme-Disease endemic area.

Authors:  R C Falco; H A Smith; D Fish; B A Mojica; M A Bellinger; H L Harris; K E Hechemy
Journal:  Am J Public Health       Date:  1993-09       Impact factor: 9.308

10.  Dogs as sentinels for Lyme disease in Massachusetts.

Authors:  J M Lindenmayer; D Marshall; A B Onderdonk
Journal:  Am J Public Health       Date:  1991-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.